Emerald Health Therapeutics (CVE:EMH) Stock Price Down 3.8% – What’s Next?

by · The Cerbat Gem

Emerald Health Therapeutics, Inc. (CVE:EMH – Get Free Report) shares traded down 3.8% during mid-day trading on Wednesday . The company traded as low as C$0.25 and last traded at C$0.26. Approximately 384,329 shares were traded during trading, a decline of 40% from the average session volume of 644,760 shares. The stock had previously closed at C$0.27.

Emerald Health Therapeutics Price Performance

The stock has a market cap of C$52.28 million and a PE ratio of -0.37. The company has a quick ratio of 2.61, a current ratio of 2.97 and a debt-to-equity ratio of 35.45. The company’s fifty day moving average is C$0.26 and its 200 day moving average is C$0.26.

Emerald Health Therapeutics Company Profile

(Get Free Report)

Emerald Health Therapeutics, Inc, together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc and changed its name to Emerald Health Therapeutics, Inc in June 2015. Emerald Health Therapeutics, Inc is headquartered in Vancouver, Canada.

See Also